Vol. 16, Issue 1, Jul-Dec 2023
Page: 104-109
Pharmaceutical Policy in India: Evolution and Development
Dr. Pulapalli Venkataramana
Received Date: 2022-04-05
Accepted Date: 2022-05-09
Published Date: 2022-05-19
The pharmaceutical sector is another important sector that contributes to the macroeconomic growth in India and significantly influenced by the Trade Related Intellectual Property Rights (TRIPs) agreement of the World Trade Organization (WTO). Indian Health and Pharmaceutical Sector is a combination of public and private management.
Back
Download PDF
References
- Report of the Task Force, 'Strategy for increasing Exports of Pharmaceutical Products,' Ministry of Commerce and Industry, Government of India, December 2008, New Delhi, Pp. 13- 22.
- ASSOCHAM, “White Paper on Indian Pharma Industry: Quest for Global Leadership,” Bombay, 2006, Pp. 15- 24.
- India Brand Equity Foundation (IBEF) Report on 'The Growth of Indian Pharmaceuticals Industry,' March 2015, New Delhi.
- Anitha Ramana, “Policy Implications of India’s Patent Reforms,” Economic and Political Weekly, Vol. 37, No. 21 (2002), Pp. 2065-2075.
- Gopa kumar and G. Nair, 'Impact of TRIPs on Indian Pharmaceutical Industry,' Journal of Intellectual Property Rights, Vol. XIII, September 2008, Pp. 436-437. The Amendment ensures exclusive marketing Rights to Patentee and prevents unauthorized persons or third parties from making, using, offering for sale, selling or importing patented product in the territorial jurisdiction of India (with exception to Research and Experiments).
- Ibid., P. 438.
- The Hindu, “Patents Legislation Worries MNCs,” July 24, 2002
- The Hindu, “New Drug Policy: Pragmatic Approach,” by Ramnath Subbu, February 14, 2002.
